Priothera
  • Home
  • Science
    • Mocravimod
    • Acute Myeloid Leukemia & Hematopoietic Cell Transplantation
    • CAR T Cells
    • Our Pipeline
    • Publications
  • MO-TRANS
  • Press
  • About
    • Our Leadership Team
    • Advisory Board
    • Investors
    • Our Partners
    • ESG and Recognition
  • Contact
Select Page

Sphingosine 1-phosphate signaling and its pharmacological modulation in allogeneic hematopoietic stem cell transplantation

https://priothera.com/sphingosine-1-phosphate-signaling-and-its-pharmacological-modulation-in-allogeneic-hematopoietic-stem-cell-transplantation/

S1P signaling: new therapies and opportunities

https://priothera.com/s1p-signaling-new-therapies-and-opportunities/

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GvHD)

https://priothera.com/insights-into-the-mechanism-of-fty720-and-compatibility-with-regulatory-t-cells-for-the-inhibition-of-graft-versus-host-disease-gvhd/
Next Entries »

Recent Posts

  • Priothera accélère sur son traitement des cancers hématologiques
  • Priothera accélère sur son traitement des cancers hématologiques
  • Priothera, la start-up Florent de Saint-Louis qui se rêve licorne
  • Pniothera pounsuit sa levée de fonds pour accélérer son traitement des cancens hématologiques
  • Priothera receives a European Union grant of nearly € 685.000 for the development of its innovative treatment for hematologic cancers

Recent Comments

  • Priothera to start Phase IIb/III trial of acute myeloid leukaemia therapy on Priothera Receives FDA clearance of Investigational New Drug (IND)
  • FDA grants orphan drug designation to mocravimod for acute myeloid leukemia - Healio - The Online Chemists on Priothera – FDA and EMA Grant Orphan Drug Designation to mocravimod for the treatment of Acute Myeloid Leukemia (AML) in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)

Priothera, Adding Quality Years to Life

Get In Touch

Priothera SAS
57 Avenue Général de Gaulle
68300 Saint-Louis, France

Priothera Ltd
88 Harcourt Street, Dublin 2,
D02 DK18, Ireland

© Priothera Ltd. 2025

Priothera SAS
57 Avenue Général de Gaulle
68300 Saint-Louis, France

Priothera Ltd
88 Harcourt Street, Dublin 2,
D02 DK18, Ireland